CEREBRAL RADIATION INJURY

This adverse event was reported 14 times

These drugs are most commonly taken by patients reporting CEREBRAL RADIATION INJURY:

# Drug Count
0 ADALIMUMAB 1
1 ADO-TRASTUZUMAB EMTANSINE 1
2 ALECTINIB HYDROCHLORIDE 1
3 BEVACIZUMAB 1
4 BRIGATINIB 1
5 CARBOPLATIN 1
6 DALTEPARIN SODIUM 1
7 DOCETAXEL 1
8 DOCETAXEL ANHYDROUS 1
9 DULAGLUTIDE 1
See all common drugs associated with CEREBRAL RADIATION INJURY

CEREBRAL RADIATION INJURY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BRIGATINIB 1 0.0003
1 ALECTINIB HYDROCHLORIDE 1 0.0001
2 ADO-TRASTUZUMAB EMTANSINE 1 0.0001
3 GEFITINIB 1 0.0001
4 DALTEPARIN SODIUM 1 0.0001
5 PERTUZUMAB 1 0.0000
6 DOCETAXEL ANHYDROUS 1 0.0000
7 DOCETAXEL 1 0.0000
8 TRASTUZUMAB 1 0.0000
9 SOMATROPIN 1 0.0000
See all drugs enriched for association with CEREBRAL RADIATION INJURY

CEREBRAL RADIATION INJURY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Recombinant Human Growth Hormone [EPC] 1 0.0000
1 HER2/neu Receptor Antagonist [EPC] 1 0.0000
2 Microtubule Inhibitor [EPC] 2 0.0000
3 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
4 Platinum-based Drug [EPC] 1 0.0000
5 Kinase Inhibitor [EPC] 2 0.0000
6 GLP-1 Receptor Agonist [EPC] 1 0.0000
See all drug classes enriched for association with CEREBRAL RADIATION INJURY